May 2004
Volume 45, Issue 13
ARVO Annual Meeting Abstract  |   May 2004
Serial electrophysiological measurements of of visual function in infantile neuronal lipofuscinosis.
Author Affiliations & Notes
  • R.C. Caruso
    Ophthalmic Genetics & Visual Function Branch, NEI, NIH, Bethesda, MD
  • Z. Quezado
    CC, NIH, Bethesda, MD
  • S.W. Levin
    WRAMC, Washington, DC
  • K.H. Fischbeck
    NINDS, NIH, Bethesda, MD
  • A.L. Gropman
    NINDS, NIH, Bethesda, MD
  • S. Hofmann
    U. Texas SW Medical Center, Dallas, TX
  • N. Patronas
    CC, NIH, Bethesda, MD
  • K. Wisniewski
    NY State Basic Research Institute, Staten Island, NY
  • Z. Zhang
    NICHD, NIH, Bethesda, MD
  • A.B. Mukherjee
    NICHD, NIH, Bethesda, MD
  • Footnotes
    Commercial Relationships  R.C. Caruso, None; Z. Quezado, None; S.W. Levin, None; K.H. Fischbeck, None; A.L. Gropman, None; S. Hofmann, None; N. Patronas, None; K. Wisniewski, None; Z. Zhang, None; A.B. Mukherjee, None.
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 5141. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      R.C. Caruso, Z. Quezado, S.W. Levin, K.H. Fischbeck, A.L. Gropman, S. Hofmann, N. Patronas, K. Wisniewski, Z. Zhang, A.B. Mukherjee; Serial electrophysiological measurements of of visual function in infantile neuronal lipofuscinosis. . Invest. Ophthalmol. Vis. Sci. 2004;45(13):5141.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose: The aim of this study was to assess abnormalities in the electroretinogram (ERG) and visual evoked potential (VEP) in infantile neuronal ceroid lipofuscinosis (INCL) (OMIM # 256730) and their rate of change during the course of a treatment trial. INCL is a neurodegenerative disease caused by mutations in the gene encoding palmitoyl–protein thioesterase (PPT), which leads to retinal degeneration and optic atrophy. Methods: Two girls with inactivating mutations in the PPT1 gene were included in a pilot clinical study conducted to determine the effect of cysteamine bitartrate (Cystagon) on INCL. Patient 1 was recorded on 5 occasions between the ages of 1.5 and 4.1 years. Patient 2 was recorded on 4 occasions between the ages of 2.1 and 3.8 years. ERGs and VEPs elicited by Ganzfeld flash stimuli were recorded according to ISCEV standards; ERGs were recorded under propofol anesthesia. Response amplitude vs. time functions were fitted with an exponential model to estimate the half–life of each response. Results: ERG responses showed a more severe b–wave reduction than a–wave reduction; this electronegative configuration implies an abnormality at, or proximal to, the photoreceptor–bipolar synapse. Rod–mediated b–waves were more compromised than cone–mediated b–waves. ERGs elicited by 150 ms stimuli showed that b–waves were more affected than d–waves. After age 2, the amplitude of all responses declined considerably with time, with a half–life of approximately 1 year (1.08 ± 0.22 years). A correlation with progressive abnormalities in retinal pigmentation was observed. The P2 peak of the flash VEP showed normal implicit time but reduced amplitude. After age 2, P2 amplitude declined even more rapidly than ERG amplitude with time, with a shorter half–life (0.41 ± 0.01 years). A correlation with progressive optic disc pallor was observed. Conclusion: INCL caused a rapidly progressive deterioration of retinal and optic nerve function. Our data did not allow us to determine if the spontaneous course of the disease would have been even more rapid than the one observed in this treatment trial. However, they emphasized the fact that a therapeutic intervention for INCL should be instituted very early in life to preserve retinal neuronal function.

Keywords: retinal degenerations: hereditary • electroretinography: clinical • electrophysiology: clinical 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.